According to GlobalData, CATALYST is one of 56 product lines sold in the US arteriotomy closure devices market; these product lines are sold by 21 different manufacturers. The price of the CATALYST device can be viewed in GlobalData’s micro pricing report and can be retrieved according to purchase date, facility type, bed size, and geographical region. Buy the report here.
The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches.
In addition, the final selling pricing of medical devices is also impacted by the discounting policy of the manufacturer. Companies such as Cardiva Medical apply discounts for their devices based on their internal business strategy, inventory control, and monthly or quarterly sales targets. In addition, sale location can also affect the final selling price of a device, both in terms of geographical region and facility type. Prices for the same medical device often vary in hospitals and health systems versus outside of hospital facilities, for example if high volume healthcare institutions can negotiate discounts or rebates based on large purchase sizes.
Cardiva Medical overview
Cardiva Medical Inc (Cardiva) designs, develops and commercializes of vascular access management products. The major products of the company include VASCADE vascular closure system (VCS) for femoral arterial access site closure post-diagnostic and interventional endovascular procedures; VASCADE MVP for Electrophysiology (EP) procedures, Cardiva Catalyst II and Cardiva Catalyst III manual compression assist devices which are designed for heparinized patients. Cardiva offers its products to physicians, surgeons and hospitals in the US and Europe. Cardiva is funded by some of the leading venture capital investors, including Canepa Healthcare LLC, Amkey Ventures LLC, PTV Healthcare Captial, and Luther King Capital Management. Cardiva is headquartered in Santa Clara, California, the US.
For a complete picture of CATALYST, Arteriotomy Closure Devices pricing in the US, buy the report here.